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Oswald Avery and the Sugar-coated Microbe
When, in 1910, Director Rufus Cole and his small staff of
scientists at the newly opened hospital ofThe Rockefeller Insti-
tute for Medical Research picked their first targets for study,
the list included poliomyelitis, syphilis, heart disease, and
lobar pneumonia. Dr. Cole chose lobar pneumonia, the greatest
killer of all, as his special problem. At the time, medicine had
no specific weapon with which to fight this "captain of the
men of death," as it was called. Its bacterial agent, pneumococ-
cus, inflamed the lungs, blocking respiration, nnd released
toxins damaging to the heart. About all physicians could do
was provide supportive care for their patients until the inevitable
life or death "crisis" (melodramatically portrayed in early
movies). More than twenty percent of those patients-fifty
thousand a year in the United States-succumbed to the invad-
ing organism.
Cole's objective was to develop a therapeutic "serum" against
the pneumococcus by inoculating horses with increasing quan-
tities of the microbes to stimulate production of antibodies
capable of arresting the disease when injected in human pa-
tients. Such a method had been used by Emil von Behring in
Germany in his successful search for a protective serum against
diphtheria. Simon Flexner, at The Rockefeller Institute, had,
in the same way, scored a parr.ial victory over epidemic cerebro-
spinal meningitis.
It was a time when infectious diseases commanded major
medical attention, and microbiology grew in glamour as it
promised to track down and control the germs that caused
them. The Rockefeller Institute was
established in 1901, and its hospital
nine years later, to be the standard
bearers of medical science in
America. This, in the minds of the
founders, meant primarily the
investigation of infectious diseases.
But Simon Flexner: the Institute's first
director, anticipated a broader scope for
the fledgling research center when he
stressed the crucial role of chemistry
in biology and medicine. Oswald
Avery, soon to join Rufus Cole's
group, would amply prove
Flexner's point. Cole and his
co-workers shared the hope that
the pneumococcus could be
mastered in the same way that
a number of other virulent
bacteria already had been.
But they soon ran into
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problems, the main one being the variety of pneumococcal
strains. As scientists abroad had discovered, these strains dif-
fered in their deadliness. The Rockefeller team also found that
the strains were different enough chemically to elicit somewhat
different antibodies in their victims. Each of the three most
common types of pneumococcus would require a different
serum. By the end of 1912, the Cole group had developed a
serum for use against type I, and they also had developed a
procedure, using laboratory mice, for determining what type
of pneumonia microbe was infecting a patient. But Cole realized
that further progress depended on an analysis of the slight
chemical differences between the pneumococcal strains. The
researcher for such a project would need a broad knowledge of
bacteriology and immunology and a talent for chemical studies.
Cole took a drive to the Hoagland Laboratory, in Brooklyn,
to see Oswald Avery, a bacteriologist then working with cultures
of pneumococcus. A paper by Avery on secondary infection in
tuberculosis patients had. caught his attention because it
demonstrated the ability to carry out a systematic clinical
investigation. Cole came away from the meeting convinced
that he had found his man. A few days later, Avery was invited
to lunch at the Institute with Dr. Flexner and, shortly after,
received a letter from Cole offering him a position as bac-
teriologist to The Rockefeller Institute Hospital. There was no
reply. Cole wrote a second letter and, when it, too, went
unanswered, drove again to Brooklyn to make Avery a more
attractive offer. He learned that Avery had ignored the initial
offer not because it was financially inadequate, but 'simply
because he had been too busy to respond.
Today Avery might be described as a late bloomer in science.
He came to the Institute at the age of thirty-six with a record
of thorough and diversified research and a competency sufficient
to gain the respect of men like Cole and Flexner. But as Avery's
biographer and colleague Rene Dubos* points out, he was
almost forty before he hit his stride as a creative scientist who,
in the quarter century that followed, was to quietly and per-
sistently make a unique series of major contributions to biomed-
ical science. This career was capped, when Avery was sixty-
seven, by the idenrifica:tion of DNA as the substance of the
genes, a discovery that opened up a new epoch in biology and
turned an ulgy duckling of a molecule into a swan.
"BABE" BECOMES "FESS"
Friends and family of the young Avery probably would not
have predicted a life in science for him. Born in Halifax, Nova
Scotia, on October 21, 1877, he was ten years old when his
father, Joseph F. Avery, a Baptist minister, received an invitation
to be pastor of a mission church at Henry Street on New York's
lower East Side, a neighborhood Dubos describes as "a melting
pot of sin" with, as Avery's mother, Elizabeth, put it, "people,
people everywhere." In the midst of the poverty and squalor
of the Bowery, the family was buoyed by the support of the
city's closely knit Baptist community and made the Mariners'
Temple a busy center of religious and social activities.
John D. Rockefeller, whose philanthropy was to create The
Rockefeller Institute, was deeply involved in the programs of
the Baptist church and frequently contributed to the Mariners'
Temple. A more personal note is struck in a letter of December
30, 1890 from Mr. Rockefeller to the Reverend Avery enclosing
a Christmas check for fifty dollars and inviting the Averys to
join the Rockefellers at their house on 54th Street for ice skating
in the backyard. "You will find an entrance on either side to
the house," wrote Jhe richest man in the country. "Put your
hand through the gate and pull the bolt."
Oswald and his older brother, Ernest, were to be seen on
Sunday afternoons playing their cornets on the steps of the
Mariners' Temple to attract worshipers. Their proficiency even-
tually won them scholarships to the National Conservatory of
Music, but the duo was sundered by Ernest's death in 1892,
the same year in which their father died. Mrs. Avery went to
work for the Baptist City Mission Society. Oswald continued
. alone as church musician with two new responsibilities: man
of the family and surrogate father to his younger brother, Roy.
In 1893, Oswald left the sidewalks of New York for the
upstate village of Hamilton to enter Colgate Academy. Three
years larer he enrolled in Colgate Universi ty. "Babe," as his
classmates dubbed him, became leader of the band, disrin-
guished himself in oratorical contests, and made excellent
grades. He was graduated with a major in the humanities. In
science, he had taken only the few basic courses that were
compulsory.
-The Profmor, The Institute, and DNA, The Rockefeller University Press, 1976.
What moved him to choose medicine as a profession is not
clear. Dubos suggests one reason may have been that "medicine
provided him with an outlet compatible with his familial mis-
sionary background." Noting also that the Reverend Frederick
Gates had recently advised Mr. Rockefeller to put some of his
fortune behind medical research, Dubos concludes: "Medicine
apparently fitted well into the mood of the Baptist community
at that time."
Avery was admitted to Columbia University's College of
Physicians and Surgeons- the science entrance requirements
were minimal-and got his degree in 1904: His career as a
practicing physician lasted only about three years and reflects
the state of medicine at the time. Although he got on well
with his patients, he was frustrated at being able to do so little
for people suffering from serious diseases. He made asomplete
break with clinical practice when he was appointed associate
director of the Hoagland Laboratory, where he learned scientific
techniques and the chemical approach to research.
Student nurses whom Avery taught at the laboratory
nicknamed him "The Professor." At Rockefeller, "The Professor"
became "Fess" to close associates. His practice of teaching by
conversation reached its peak in the "Red Seal Records," so
called by his colleagues because of his beautifully planned and
delivered explanations of his research.
THE CAPSULE WAS THE CULPRIT
The problem of Avery's lifetime was, in the words of colleague
Rollin Hotchkiss, "that little gram-positive coccus, which he
felt presented in small compass most of the basic questions of
biology." The source of the pneumococcus's virulence was un-
known when Avery, installed by Cole in a laboratOry made over
from a disused ward kitchen, joined forces with pathologist
Alphonse Dochez, with whom he would also share an apartment
for many years. Their "midnight dialogues," as Dubos calls
them, turned many evenings at home into spirited and creative
exchanges of scientific ideas.
One of their most significant discoveries was the role played
in disease by the coating or capsule of clear gelatinous material
that encloses virulent pneumococci. Scientists had suspected
some association but it had not been investigated. Dochez and
Avery made their first step in this direction in 1917 when they
found a substance in culture fluids of pneumococcus, filtered
to remove bacteria, that reacted to pneumococcal antisera in a
type-specific manner. That is to say, culture fluids in which
type I pneumococci had grown would react only with type I
antisera, type II cultures with type II antisera, and so on.
Further research showed that this substance, which they called
"specific soluble substance," Ot SSS for short, was present in
the urine of pneumonia patients. Knowing this, it was possible
to diagnose the pneumococcus involved by a urine test when
a patient entered the hospital. Meanwhile, as evidence accumu-
lated that the pneumococcal capsule was essential for viru-
lence-bacteria that had lost their coats in culture could not
infect-Avery had discovered that SSS was present in the cap-
sules.
In the midst of the laboratory's other studies, including the
development of a serum therapy for pneumonia which remained
the only therapy available until the advent of antibiotics, Avery
continued his quest for the chemical nature of SSS. Frustrated,
he sought help from Michael Heidelberger, a young chemist
in another laboratOry. Busy with a project for his ,own lab
leader, Heidelberger kept Avery waiting. Meeting Heidelberger
in the corridor, Avery would hold up a small vial of brownish
powder and ask, "When can you work on this, Michael? The
whole secret of specificity is in the vial."
By 1922, Heidelberger was ready and the two went to work
extracting the chemical ingredients of the capsule and testing
them for their immunological reactions. They found that chem-
ical differences in the capsular substances of the types of
pneumococcus were responsible for differences in the microbes'
virulence and the specific antibodies they induced in the pa-
tient. The capsule was the culprit, but what was it made of?
The answer was a, surprise. When Avery and Heidelberger
analyzed the specific substances of the capsules they turned out
to be polysaccharides, complex structures of linked sugar
molecules. Hence, Avery's nickname for the virulent
pneumococcus-"the sugar-coated microbe." Because up to
that time it was generally assumed that only proteins could
incite an'immune response in a host, the discovery met with
considerable skepticism. Then the finding was carried a step
further by Walther F. Goebel, who joined the Avery group in
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"Babe," front center, with the
, Colgate University band.
"Fess" andhis laboratory group,
circa 1932, with Walther Goebel,
seatedfar right, and Rene Dubos,
standing third from left.
Colin MacLeod, left, andMaclyn
McCarty at the dedication ofthe
Awry gate in 1965.
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1925. Goebel split the immense polysaccharides-literally
"many sugars"-into the simple sugars of which they were
composed, and showed that the specificity of a given
pneumococcal strain depended upon whatever set of sugars
formed its capsule.
The volume and range of Avery's scientific output increased
rapidly. Only vacations at Deer Island, in Maine, where he
became an ardent sailor, interrupted his laboratory routine.
When alone, associates recall, he moved about slowly whistling
the plaintive shepherd's song from Tristan and Isolde. Although
immensely popular, he rarely accepted any of the social invita-
tions he received. He hardly ever traveled, even to accept the
many awards that marked his achievements.
DNA-THE LONG SHOT
The research that led to Avery's greatesr discovery had its roOts
in work reported in 1928 by Frederick Griffith, a medical
officer in the Ministry of Health in London, who claimed that
pneumococci might lose their polysaccharides and then be in-
duced to switch types under special circumstances. Griffith
had observed that when mice were injected with a mixture of
live bacteria that had lost their capsules, and were therefore
harmless, together with heat-killed virulent pneumococci of a
different type, the animals died of the infection. The
pneumococci recovered from the mice's blood were now the
same type as the heat-killed organisms.
Griffith was a well-established investigator with a reputation
for care in experimentation. Nonetheless his description of
pneumococcal "transformation," the term applied to this switch
in immune specificity, strained the belief of other investigators,
including Avery. The accepted view was that descendants from
one type of pneumococcus always remained true to type. Avery
changed his mind when Griffith's findings were later duplicated
by other scientists, including members of his own laboratory.
What followed was a decade of research aimed at identifying
the transforming substance responsible for transmissible
changes in the immunological specificity of pneumococci.
The work got off to a slow start. Avery was sidelined for
months by thyroid surgery, and throughout a good deal of the
period there was the press of other projects. Above all, there
were enormous technical difficulties. Several colleagues recall
Avery's backward-looking observation: "Many are the times we
were ready to throw the whole thing out the window." Indis-
pensible to the ultimate success of the research were the con-
tributions of two brilliant young collaborators, Colin M. Mac-
Leod and Maclyn McCarty.
Finally, in 1944, Avery, Macleod, and McCarty published
in the Journal of Experimental Medicine what is now considered
one of the landmark papers in the history of biological science,
"Studies on the Chemical Nature of the Substance Inducing
Transformation of Pneumococcal Types: Induction of Transfor-
mation by Desoxyribonucleic Acid Fraction Isolated from
Pneumococcus Type III." The meaning? The agent of trans-
formation in pneumococcal types is what is now called
deoxyribonucleic acid: DNA. The inference, which Avery and
his team clearly understood and which subsequent research
(most importantly by Rollin Hotchkiss) confirmed, was that
the agent of transformation was the genetic material. In other
words, the genes of pneumococcus were made of DNA.
Today, when DNA has become a household word, it is dif-
ficult to imagine the impact of the paper. DNA was a very
long shot as a candidate for genetic honors. Proteins, more
complex and more intricately folded molecules, were the favor-
ites. Avery and his colleagues faced considerable challenge.
Like Griffith's, their experimental methods and chemical
analyses were suspected of flaws. Dr. McCarty has told the
story in fascinating detail in his book, The Transforming Principle,
written in part in his Rockefeller office where the laboratory
notebooks from the climactic years of the DNA research are
lined up on a shelf behind his desk. The memoir is dedicated
to "Oswald Theodore Avery, who was not inclined to write
such a book, and Colin Munro Macleod, who ran out of time
before he could do it."
Avery retired in 1943 and later went to Nashville, Tennessee,
to live near his brother Roy, who taught bacteriology at Vander-
bilt University, and his family. He died of cancer on February
20, 1955.
At the northwest corner of the Rockefeller campus a granite
gateway had been erected in his name-a somewhat massive
memorial for someone who never weighed much more than. a
hundred pounds, but a fitting one for the scientist who opened
the way to a new biology. 0
